Pazocent 200 mg tablet

Pazocent is indicated for the treatment of patients with advanced renal cell carcinoma (RCC). Pazocent is indicated for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. The efficacy of Pazocent for the treatment of patients with adipocytic STS or gastrointestinal stromal tumors has not been demonstrated. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'

Add to cart